Back to Search
Start Over
Evaluation of pancreatic VMAT2 binding with active and inactive enantiomers of 18 F-FP-DTBZ in baboons.
- Source :
-
Nuclear medicine and biology [Nucl Med Biol] 2016 Dec; Vol. 43 (12), pp. 743-751. Date of Electronic Publication: 2016 Sep 02. - Publication Year :
- 2016
-
Abstract
- Introduction: <superscript>18</superscript> F-Fluoropropyl-(+)-dihydrotetrabenazine ( <superscript>18</superscript> F-FP-(+)-DTBZ) is a vesicular monoamine transporter type 2 (VMAT2) radiotracer for positron emission tomography (PET) imaging to quantify human β-cell mass. Renal cortex and spleen have been suggested as reference regions, however, little is known about <superscript>18</superscript> F-FP-(+)-DTBZ binding in these regions including the fraction of radiometabolite. We compared the kinetics of <superscript>18</superscript> F-FP-(+)-DTBZ and its inactive enantiomer <superscript>18</superscript> F-FP-(-)-DTBZ in baboons, estimated the non-displaceable binding (V <subscript>ND</subscript> ) of the tracers, and used ex vivo studies to measure radiometabolite fractions.<br />Methods: PET scans were conducted for up to 4h with (+) and (-) enantiomers. Displacement experiments using unlabeled (+) and (-) enantiomers of FP-DTBZ and fluvoxamine (to evaluate sigma-1 receptor binding) were performed. SUV curves were used to calculate displacement values in the pancreas, renal cortex, and spleen. Distribution volumes (V <subscript>T</subscript> ) were computed, and three approaches for calculation of V <subscript>ND</subscript> were compared: (1) <superscript>18</superscript> F-FP-(+)-DTBZ reference V <subscript>T</subscript> , (2) <superscript>18</superscript> F-FP-(-)-DTBZ pancreatic V <subscript>T</subscript> , and (3) a scaled <superscript>18</superscript> F-FP-(+)-DTBZ reference V <subscript>T</subscript> values. Ex vivo study was conducted to measure radiometabolite fraction in homogenized tissue samples from baboons at 90min post-injection.<br />Results: Spleen uptake was lowest for both tracers. Highest uptake was in the pancreas with <superscript>18</superscript> F-FP-(+)-DTBZ and renal cortex with <superscript>18</superscript> F-FP-(-)-DTBZ. Substantial displacement effect was observed only with unlabeled FP-(+)-DTBZ in the <superscript>18</superscript> F-FP-(+)-DTBZ studies. Radiometabolite fraction was higher in the renal cortex than the spleen. Approaches (1) and (3) with spleen to estimate V <subscript>ND</subscript> provided lowest inter-subject variability of BP <subscript>ND</subscript> .<br />Conclusions: V <subscript>T</subscript> differences among organs and between enantiomers indicated that scaling of reference region values is needed for quantification of VMAT2 binding in the pancreas with <superscript>18</superscript> F-FP-(+)-DTBZ. Since the kidney PET signal has greater partial volume averaging and more radiometabolites, the spleen was considered a more practical candidate for use as a scaled-reference region in the quantification of <superscript>18</superscript> F-FP-(+)-DTBZ in the pancreas.<br /> (Copyright © 2016 Elsevier Inc. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1872-9614
- Volume :
- 43
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Nuclear medicine and biology
- Publication Type :
- Academic Journal
- Accession number :
- 27673755
- Full Text :
- https://doi.org/10.1016/j.nucmedbio.2016.08.018